Literature DB >> 20659078

Effects of latex avoidance on latex sensitization, atopy and allergic diseases in patients with spina bifida.

K Blumchen1, P Bayer, D Buck, T Michael, R Cremer, C Fricke, T Henne, H Peters, U Hofmann, T Keil, M Schlaud, U Wahn, B Niggemann.   

Abstract

BACKGROUND: Ten years ago, avoidance measures such as the performance of latex-free operations were implemented in children with spina bifida. Since then, latex sensitization and latex allergy have decreased in this high-risk group.
OBJECTIVE: To study the effect of primary latex-free prophylaxis on the prevalence of allergic diseases and atopy as a marker for sensitization spreading in children with spina bifida.
METHODS: One hundred and twenty children with spina bifida born after the introduction of latex-free prophylaxis and operated on under latex-free conditions ('current group') were examined for latex sensitization, latex allergy, sensitization to aero- and food allergens and allergic diseases. Results were compared to a 'historic' (not latex-free operated) group of children with spina bifida and comparable age (n = 87) and to a recent sample of children from the general population (n = 12,403).
RESULTS: In comparison with the 'historic group', latex sensitization (55% vs 5%, P < 0.001) and latex allergy (37% vs 0.8%, P < 0.001) were significantly reduced in the 'current group'. Furthermore, a significant reduction could be demonstrated for sensitization to aeroallergens (41.4% vs 20.8%, P = 0.001) and for allergic diseases (35% vs 15%, P = 0.001). The prevalence for atopy, sensitization to aero-/foodallergens and for allergic diseases in children of the 'current group' was similar to those in children of the weighted population sample.
CONCLUSIONS: Latex avoidance in children with spina bifida prevents latex sensitization and latex allergy. Additionally, it also seems to prevent sensitization to other allergens and allergic diseases which might be explained by the prevention of sensitization spreading.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659078     DOI: 10.1111/j.1398-9995.2010.02447.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

1.  Structural analysis of the endogenous glycoallergen Hev b 2 (endo-β-1,3-glucanase) from Hevea brasiliensis and its recognition by human basophils.

Authors:  Adela Rodríguez-Romero; Alejandra Hernández-Santoyo; Deyanira Fuentes-Silva; Laura A Palomares; Samira Muñoz-Cruz; Lilian Yépez-Mulia; Socorro Orozco-Martínez
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-01-29

Review 2.  Current prevalence rate of latex allergy: Why it remains a problem?

Authors:  Miaozong Wu; James McIntosh; Jian Liu
Journal:  J Occup Health       Date:  2016-03-24       Impact factor: 2.708

3.  Latex allergy guidelines for people with spina bifida.

Authors:  Veronica Meneses; Sarah Parenti; Heather Burns; Richard Adams
Journal:  J Pediatr Rehabil Med       Date:  2020

4.  Prevalence of latex allergy in spina bifida patients in Singapore.

Authors:  Xiuzhen Chua; Javid Mohamed; Hugo Ps van Bever
Journal:  Asia Pac Allergy       Date:  2013-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.